1. History
Transposition of the great arteries (TGA) is the cyanotic congenital heart malformation of greatest clinical importance, first described as an autopsy case by Matthew Baillie (1797) in the late 18th century. Until the early 20th century there was no surgical treatment, and death on diagnosis was unavoidable. In the 1950s~60s, the Blalock-Hanlon procedure (atrial septectomy) was used as short-term palliative treatment, and in 1966 Rashkind and Miller developed balloon atrial septostomy (BAS), which became the standard emergency neonatal treatment. As atrial-level repair, after Lillehei's attempt in 1953, Senning published an intra-atrial baffle procedure using atrial tissue in 1959, and Mustard established the patch-based Mustard procedure in 1964. Atrial-level repair succeeded in normalizing the circulation but had the structural limitation that the subpulmonic ventricle (morphologic right ventricle) bears the systemic load. In 1975, Jatene of Brazil published the first successful arterial switch operation (ASO), anatomically switching the great vessels and, through coronary artery transfer, achieving physiological correction in which the left ventricle supports the systemic circulation. Thereafter ASO became established as the standard operation for simple TGA and spread worldwide in the 1980s~90s.
2. Causes
The cause of D-TGA involves a combination of genetic and environmental multifactorial factors, and the key pathogenic mechanism is understood to be general disruption of the outflow tract rotation process rather than a specific single cause. Genetically, variants in CFC1 (a left-right asymmetry determining gene), DNAI1, DNAI2, and ZIC3 (an X-linked gene involved in left-right axis determination) have been reported in some TGA patients. 22q11.2 deletion accompanies about 5% of complex TGA (TGA + VSD + pulmonary stenosis). TBX1, NKX2-5 single-nucleotide variants, and HAND2 heterozygous variants have also been reproduced in animal models of TGA. As an environmental risk factor, early-pregnancy diabetes exposure is well established to increase the risk of TGA 2~3-fold. In addition, first-trimester influenza infection, trimethoprim-sulfamethoxazole use, and excessive vitamin A intake have been proposed as risk factors. A 2~3-fold higher incidence in boys than in girls is consistently reported, suggesting the existence of a sex-linked protective or vulnerability mechanism that has not yet been clearly identified.
3. Genetics
The genetic architecture of D-TGA is complex, and most cases occur sporadically. The recurrence risk is reported to be slightly higher than in the general population (sibling recurrence rate about 1~2%), but a clear Mendelian inheritance pattern is rare. De novo variants are identified in about 10~15% of TGA, and ZIC3 (Xq26.2) variants in particular cause left-right asymmetric cardiac malformations in an X-linked dominant manner. Variants in the Nodal signaling pathway (CFC1, FOXH1, ACVR2B) cause abnormal determination of left-right atrial asymmetry, leading to situs inversus including TGA and cardiac abnormalities. GATA4, NKX2-5, TBX1, and TBX5 variants sometimes include TGA as part of the phenotype of complex cardiac malformations. Recent whole-exome sequencing studies have found new candidate genes such as HMGA2 and ACTN2. In prenatal genetic counseling, associated syndromes are excluded and recurrence risk is assessed through chromosomal microarray and WES/WGS.
4. General epidemiology
D-TGA has an incidence of about 2~3 per 10,000 live births (0.02~0.03%) and is the most common single malformation among cyanotic congenital heart malformations. About 14,000~20,000 are estimated to be born worldwide each year. In Korea, about 50~80 new cases per year are diagnosed according to Health Insurance Review & Assessment Service data. There is a marked sex bias, with an incidence about 2~3 times higher in boys than in girls. About 50% are simple TGA (intact ventricular septum, IVS), about 35~40% are TGA with VSD, and 10~15% accompany VSD + pulmonary stenosis (pulmonary stenosis type). Common associated malformations are patent ductus arteriosus (PDA), atrial septal defect (ASD), and coronary artery anomalies, and anomalies of coronary origin (single coronary artery, circumflex coronary artery) have a decisive influence on surgical planning. The risk of occurrence is increased in low-birth-weight infants, premature infants, and children of diabetic mothers.
5. Pathophysiology
The heart begins to develop at the end of the third week of embryonic development when two endocardial tubes originating from the lateral plate mesoderm fuse in the midline to form a single heart tube. The heart tube then loops to the right (rightward looping, D-looping) so that the atria, ventricles and outflow tract are arranged in sequence, and outflow tract septation, valve formation and separation of the great vessels are completed through neural crest cell migration and the influx of second heart field (SHF) cells. Transcription factors regulating this process include NKX2-5, GATA4, TBX1, TBX5, HAND1/2 and ISL1, and variants in these genes or environmental disruption constitute the common pathogenetic mechanism of congenital heart malformations.
D-TGA arises when the spiral twisting of the conal septum does not occur normally during weeks 5~7 of embryonic development, resulting in the aorta and pulmonary artery arising from the opposite ventricles. Normally the aorta should lie posterior to the upper left ventricle and the pulmonary artery anterior to the upper right ventricle, but in TGA the aorta is positioned right-anterior and the pulmonary artery left-posterior (D-transposition). As a result, the systemic and pulmonary circulations form parallel circuits, and oxygenated blood (pulmonary veins → left atrium → left ventricle → pulmonary artery → lungs) and deoxygenated blood (systemic veins → right atrium → right ventricle → aorta → whole body) circulate independently without mixing. In the fetal period, blood mixing occurs through the foramen ovale and ductus arteriosus, but after birth when these mixing pathways close, severe hypoxemia occurs immediately. Abnormal neural crest cell migration, disturbed SHF signaling, and incomplete conal resorption are involved in combination, and abnormalities of the ZIC3, CFC1, and Nodal pathways lead to failure of left-right asymmetry signaling, resulting in outflow tract malalignment after D-looping.
6. Symptoms
D-TGA is an emergency congenital heart malformation in which severe central cyanosis is the main symptom from immediately after birth. The cyanosis does not respond to improved breathing or oxygen administration (oxygen-refractory cyanosis), which is an important clue for diagnosis. In simple TGA (IVS), there is no heart murmur or only a mild one at birth, making early detection by murmur difficult. In the absence of an atrial-level shunt (foramen ovale, ASD) or VSD, oxygen saturation falls rapidly to the 40~60% level immediately after birth and emergency treatment is needed. In TGA + VSD, blood mixing occurs through the VSD so cyanosis is relatively less severe, but pulmonary blood flow is excessive and symptoms of congestive heart failure (tachypnea, feeding difficulty, poor growth) appear within several weeks. In TGA + VSD + pulmonary stenosis (Rastelli type), cyanosis is severe owing to decreased pulmonary blood flow but heart failure is rare. Untreated simple TGA is a fatal malformation in which more than 90% die within the first year of life.
7. Signs
On neonatal physical examination, central cyanosis (blue lips, mucous membranes, and nails) is observed immediately. Pulse oximetry (SpO₂) shows hypoxemia in both the right upper limb and the lower limbs (SpO₂ 50~70%), and when the PDA is widely open, a right-to-left shunt may cause paradoxical differential cyanosis with lower limb SpO₂ lower than upper limb. On chest auscultation, simple TGA has no heart murmur or only a mild one, and the second heart sound (S2) is heard as single and accentuated. With VSD, a holosystolic murmur is added. On chest X-ray, increased pulmonary vascular markings and an 'egg-shaped' cardiac silhouette (egg-on-a-string) are the classic findings but may be nonspecific in the neonatal period. The ECG is similar to a normal neonatal ECG and has low value for early diagnosis. Echocardiography confirms the arrangement in which the aorta arises anteriorly from the right ventricle and the pulmonary artery arises posteriorly from the left ventricle, with the great vessels running in parallel.
8. Screening
Prenatal screening is performed with detailed fetal echocardiography at 18~22 weeks of gestation, and the finding that the two great vessels do not cross normally but run in parallel on the outflow tract view (parallel great arteries) is the key prenatal sign of TGA. In domestic and international studies the prenatal diagnosis rate is at the 40~60% level, and when diagnosed prenatally, planned delivery and immediate BAS significantly improve the prognosis. For postnatal screening, neonatal congenital heart disease screening (pulse oximetry at 24~48 hours of life, SpO₂ of the right upper limb + sole) contributes to early detection of severe cyanotic cardiac malformations including TGA. Immediate echocardiography is recommended when SpO₂ of the right upper limb or lower limb is <95%, or the right upper limb-lower limb difference is >3%. In high-risk groups (diabetic mothers, family history of congenital heart malformation, suspicious prenatal findings), a system of consultation with pediatric cardiology before delivery is established to keep the team on standby for treatment immediately after birth. If TGA is immediately suspected on echocardiographic screening, prostaglandin E1 (PGE1) is administered to maintain ductal patency during transport.
9. Diagnosis
Diagnosis of D-TGA is established by echocardiography, followed by additional imaging evaluation for surgical planning. On echocardiography, the atrial position (S), ventricular loop (D-loop), and great vessel connection (D, L transposition) are described using the Van Praagh segmental analysis. D-TGA shows the arrangement of atrial situs solitus, ventricular D-loop, and D-transposition of the great vessels {S,D,D}. The aorta-pulmonary artery spatial relationship (anterior/posterior, right/left), presence and location of VSD (muscular, perimembranous, outlet), presence and anatomy of pulmonary stenosis, and coronary artery origin and course are evaluated in detail. Because coronary artery anomalies are decisive for ASO surgical planning, systematic description according to the Leiden classification is needed (most common form: 1LCx 2R, i.e., a pattern in which the right coronary artery alone gives off the anterior and posterior branches). Cardiac CT angiography is used to confirm coronary artery origin and three-dimensional outflow tract anatomy. Associated abnormalities are excluded by chromosomal microarray testing, prenatally or after birth.
10. Treatment
The definitive treatment of D-TGA is the arterial switch operation (ASO), performed in the neonatal period (generally within 2 weeks of life).
1) Emergency treatment: balloon atrial septostomy (BAS)
An atrial-level shunt is secured immediately after birth to increase mixing of oxygenated blood. A Rashkind balloon catheter is used under echocardiographic or fluoroscopic guidance. The goal is to maintain SpO₂ at 75% or above. The ductus arteriosus is kept open with an IV infusion of PGE1 (alprostadil) while preparing for definitive surgery.
2) Arterial switch operation (ASO) — Jatene procedure
Under cardiopulmonary bypass, the ascending aorta and main pulmonary artery are transected above the semilunar valves. LeCompte maneuver: the pulmonary artery is moved anterior to the aorta (anastomosis of the pulmonary artery anterior to the aorta) to restore the right ventricle-pulmonary artery connection. Coronary artery transfer: the coronary ostia are excised as buttons and transferred to the neo-aorta (the former pulmonary root). The neo-pulmonary artery (the former aorta) is anastomosed above the pulmonary valve. An accompanying VSD is closed with a patch during the same operation. Result of surgery: the anatomically normal arrangement is completed, with the left ventricle supporting the systemic circulation and the right ventricle supporting the pulmonary circulation.
3) Complex TGA (VSD + pulmonary stenosis): Rastelli or Nikaidoh procedure
Left ventricle-aorta connection through an intraventricular tunnel + insertion of a right ventricle-pulmonary artery external conduit (Rastelli). Alternatively, the aortic root translocation procedure (Nikaidoh), which attempts a more natural anatomical correction, is also applied.
4) Atrial-level repair (historical method)
The Senning and Mustard procedures have now been replaced by ASO, but when patients from the pre-ASO era have reached adulthood, surveillance of subpulmonic ventricular function and management of related complications are needed.
11. Prognosis
After ASO, the operative survival of simple TGA now reaches the 95~98% level, and 10-year survival is 90% or more. In complex TGA (with VSD, atypical coronary arteries), operative mortality is somewhat higher at the 3~8% level, but lower mortality is reported at specialized centers. As a long-term complication, neo-pulmonary stenosis occurs in 5~15% and reintervention (catheter balloon dilation, stent, reoperation) is required. Coronary artery stenosis or occlusion is rare (1~5%) but can cause myocardial ischemia and sudden death, so regular imaging surveillance is needed. Aortic valve regurgitation (neo-aortic) may progress in the long term, and aortic root dilation accompanies in some cases. Neurodevelopmental outcomes are related to the preoperative hypoxemic period and cardiopulmonary bypass time, and learning disabilities and attention deficits may appear after school age, so neurodevelopmental follow-up is recommended. In adult survivors after atrial-level repair (Mustard/Senning), systemic right ventricle dysfunction, arrhythmia (atrial flutter, complete atrioventricular block), and baffle obstruction/leak are the main management challenges.
12. Prevention
No specific preventive method for D-TGA has been established, but general principles of prevention of congenital heart malformations apply. Folic acid supplementation (400~800 μg/day) before and in early pregnancy contributes to reducing the overall risk of congenital heart malformation. There is sufficient evidence that optimal glycemic control of pregestational diabetes (HbA1c <6.5%) reduces the risk of congenital heart malformations including TGA. Potential teratogens such as trimethoprim-sulfamethoxazole and valproic acid are avoided during pregnancy where possible or switched to alternatives. Influenza vaccination is recommended to prevent first-trimester influenza. If TGA is suspected on detailed prenatal ultrasound, the patient is referred immediately to a fetal echocardiography specialty center, and once the diagnosis is confirmed, delivery is planned at a tertiary institution with a specialized congenital heart surgery team. Securing continuity of care from immediately after birth through BAS, PGE1 administration, and ASO by means of prenatal diagnosis and planned delivery is key to optimizing prognosis.
References
- Jatene AD, et al. Successful anatomic correction of transposition of the great vessels. J Thorac Cardiovasc Surg. 1982;83(1):20-26. [PMID 7054024]
- Rashkind WJ, Miller WW. Creation of an atrial septal defect without thoracotomy. JAMA. 1966;196(11):991-992. [PMID 5939568]
- Mustard WT. Successful two-stage correction of transposition of the great vessels. Surgery. 1964;55:469-472. [PMID 14142437]
- Losay J, et al. Late outcome after arterial switch operation for transposition of the great arteries. Circulation. 2001;104(12 Suppl 1):I121-126. [PMID 11568041]
- Khairy P, et al. Long-term survival, modes of death, and predictors of mortality in patients with Fontan surgery. Circulation. 2008;117(1):85-92. [PMID 18071068]
- Legendre A, et al. Outcomes after the arterial switch operation in neonates with transposition of the great arteries. J Thorac Cardiovasc Surg. 2014;148(6):2692-2697. [PMID 25218536]
- Brown JW, et al. Long-term results after the arterial switch operation. Ann Thorac Surg. 2001;72(1):22-29. [PMID 11465231]
- Hoffman JI, Kaplan S. The incidence of congenital heart disease. J Am Coll Cardiol. 2002;39(12):1890-1900. [PMID 12084585]
- Pierpont ME, et al. Genetic basis for congenital heart disease: revisited. Circulation. 2018;138(21):e653-e711. [PMID 30571578]
- Warnes CA, et al. ACC/AHA 2008 guidelines for the management of adults with congenital heart disease. J Am Coll Cardiol. 2008;52(23):e143-263. [PMID 19038677]